Liu Z - Search Results

1

Pathological response and predictive role of tumour-infiltrating lymphocytes in HER2-positive early breast cancer treated with neoadjuvant pyrotinib plus trastuzumab and chemotherapy (Panphila): a multicentre phase 2 trial.

Liu Z, Wang C, Chen X, Zhu J, Sun X, Xia Q, Lu Z, Qiao J, Zhou Y, Wang H, Wang Y, Yan M. Liu Z, et al. Eur J Cancer. 2022 Apr;165:157-168. doi: 10.1016/j.ejca.2022.01.022. Epub 2022 Feb 27. Eur J Cancer. 2022. PMID: 35235873 Free article. Clinical Trial.

2

[Predicative value of 99mTc-MIBI scintimammography in neoadjuvant chemotherapeutic effect of patients with operable breast cancer].

Liu ZZ, Lu ZD, Liu H, Li LF, Zhang HW, Yang H, Li WL, Cui SD. Liu ZZ, et al. Zhonghua Yi Xue Za Zhi. 2011 Feb 15;91(6):382-4. Zhonghua Yi Xue Za Zhi. 2011. PMID: 21418909 Chinese.

3

Dysregulated expression of dicer and drosha in breast cancer.

Yan M, Huang HY, Wang T, Wan Y, Cui SD, Liu ZZ, Fan QX. Yan M, et al. Pathol Oncol Res. 2012 Apr;18(2):343-8. doi: 10.1007/s12253-011-9450-3. Epub 2011 Sep 7. Pathol Oncol Res. 2012. PMID: 21898071 Free article.

4

Enrichment of breast cancer stem cells using a keratinocyte serum-free medium.

Liu ZZ, Chen P, Lu ZD, Cui SD, Dong ZM. Liu ZZ, et al. Chin Med J (Engl). 2011 Sep;124(18):2934-6. Chin Med J (Engl). 2011. PMID: 22040505

5

[Predictive value of (99)Tc(m)-MIBI scintimammography in evaluation of the efficacy of neoadjuvant chemotherapy in patients with operable breast cancer].

Liu ZZ, Lu ZD, Zhang HW, Yang H, Liu H, Li LF, Li WL, Cui SD. Liu ZZ, et al. Zhonghua Zhong Liu Za Zhi. 2011 Jul;33(7):544-6. Zhonghua Zhong Liu Za Zhi. 2011. PMID: 22093636 Chinese.

6

miR-155 and miR-31 are differentially expressed in breast cancer patients and are correlated with the estrogen receptor and progesterone receptor status.

Lu Z, Ye Y, Jiao D, Qiao J, Cui S, Liu Z. Lu Z, et al. Among authors: liu z. Oncol Lett. 2012 Nov;4(5):1027-1032. doi: 10.3892/ol.2012.841. Epub 2012 Aug 3. Oncol Lett. 2012. PMID: 23162645 Free PMC article.

7

High risk factors of brain metastases in 295 patients with advanced breast cancer.

Yan M, Lü HM, Liu ZZ, Liu H, Zhang MW, Sun XB, Cui SD. Yan M, et al. Chin Med J (Engl). 2013 Apr;126(7):1269-75. Chin Med J (Engl). 2013. PMID: 23557557

8

[Analysis of predictive factors affecting sentinel lymph node status in early breast cancer patients].

Jiao D, Qiao J, Lu Z, Li L, Zhang H, Liu H, Cui S, Liu Z. Jiao D, et al. Among authors: liu z, liu h. Zhonghua Zhong Liu Za Zhi. 2014 Mar;36(3):198-201. Zhonghua Zhong Liu Za Zhi. 2014. PMID: 24785280 Chinese.

9

[Influencing factors of pathologic complete response after neoadjuvant chemotherapy in locally advanced breast cancer patients: results of a single-center 10-year retrospective study].

Qiao J, Jiao D, Lu Z, Zhu J, Cui S, Liu Z. Qiao J, et al. Among authors: liu z. Zhonghua Yi Xue Za Zhi. 2014 May 13;94(18):1401-4. Zhonghua Yi Xue Za Zhi. 2014. PMID: 25142991 Chinese.

10

Clinical significance of topoisomerase 2A expression and gene change in operable invasive breast cancer.

Qiao JH, Jiao DC, Lu ZD, Yang S, Liu ZZ. Qiao JH, et al. Tumour Biol. 2015 Sep;36(9):6833-8. doi: 10.1007/s13277-015-3390-6. Epub 2015 Apr 7. Tumour Biol. 2015. PMID: 25846735

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

91,179 results

Search Page

Filters